AstraZeneca PLC
[WKN: 886455 | ISIN: GB0009895292]
128,000€ -0,23%
Echtzeit-Aktienkurs AstraZeneca PLC
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Truqap approved in US for HR+ breast cancer

17 November 2023 Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer First-in-class AKT inhibitor has potential to reshape…

AstraZeneca: Jahresziele erhöht - Aktienanalyse

Kulmbach ( - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des…

Director Declaration

9 November 2023 15:00 BST Director Declaration AstraZeneca PLC (the Company) today announced that Philip Broadley,senior independent Non-Executive Directorof the Company, has…

Agreement with Eccogene for clinical stage GLP-1RA

09 November 2023 AstraZeneca licenses novel agent for the treatment of cardiometabolic conditions and obesity Global rights to Eccogenes next-generation oral glucagon-like…

9M and Q3 2023 results

AstraZeneca 9 November 2023 9M and Q3 2023 results Strong momentum in the year to date leads to increased guidance for Total Revenue…

Tagesvorschau: Termine am 09. November 2023

Viele Unternehmen, unter anderem Merck KGaA, Sony, Astrazeneca, legen heute ihre Zahlen vor. Außerdem stehen wichtige Wirtschaftsdaten aus China, Japan…

Total Voting Rights

1 November 2023 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…